| scholarly article | Q13442814 |
| P50 | author | Tricia H Burdo | Q103027533 |
| P2093 | author name string | Kenneth C Williams | |
| Andrew D Miller | |||
| Joshua A Walker | |||
| Jennifer H Campbell | |||
| Graham A Beck | |||
| P2860 | cites work | Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES | Q24304260 |
| Monocytes as regulators of inflammation and HIV-related comorbidities during cART | Q27006827 | ||
| HIV infection and cardiovascular disease | Q27008915 | ||
| Anti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection | Q27322602 | ||
| HIV infection and the risk of acute myocardial infarction | Q27347231 | ||
| How Natalizumab Binds and Antagonizes 4 Integrins | Q27679979 | ||
| Cardiovascular Complications of HIV-Associated Immune Dysfunction | Q28084981 | ||
| A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis | Q29616119 | ||
| Cardiovascular manifestations in human immunodeficiency virus-infected patients. | Q30371563 | ||
| Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis | Q32054951 | ||
| The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals | Q33505475 | ||
| Increased arterial inflammation relates to high-risk coronary plaque morphology in HIV-infected patients | Q33623429 | ||
| Elevated numbers of CD163+ macrophages in hearts of simian immunodeficiency virus-infected monkeys correlate with cardiac pathology and fibrosis | Q33828245 | ||
| Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. | Q33919945 | ||
| Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. | Q33962303 | ||
| Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. | Q34026982 | ||
| Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis | Q34171790 | ||
| SIV cardiomyopathy in non-human primates | Q34416501 | ||
| Pathogenesis of HIV-associated cardiovascular complications | Q34547836 | ||
| Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents | Q34592841 | ||
| Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/alpha 4 beta 1 integrin interactions | Q35833373 | ||
| Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort | Q35937771 | ||
| Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life | Q36533831 | ||
| The relationship between myocardial extracellular matrix remodeling and ventricular function | Q36578692 | ||
| Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial | Q36765204 | ||
| Arterial inflammation in patients with HIV. | Q37046942 | ||
| The role of monocytes in atherosclerotic coronary artery disease. | Q37766875 | ||
| Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes | Q37861493 | ||
| Cardiovascular disease in human immunodeficiency virus | Q38206287 | ||
| Risk of coronary heart disease in patients with HIV infection | Q38261508 | ||
| Differing association of macrophage subsets with atherosclerotic plaque stability. | Q40094166 | ||
| Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1. | Q40214644 | ||
| Early aortic valve inflammation precedes calcification: a longitudinal FDG-PET/CT study | Q41667815 | ||
| Myocardial and microvascular inflammation/infection in patients with HIV-associated pulmonary artery hypertension. | Q42198747 | ||
| CCR5 inhibition prevents cardiac dysfunction in the SIV/macaque model of HIV. | Q42227332 | ||
| Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patients | Q42228871 | ||
| Myocarditis and cardiomyopathy HIV associated. | Q44036645 | ||
| Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol | Q44136766 | ||
| Reduced bone mineral density in HIV-infected patients: prevalence and associated factors | Q44427873 | ||
| Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation | Q45020438 | ||
| Diastolic dysfunction is associated with myocardial viral load in simian immunodeficiency virus-infected macaques | Q45359942 | ||
| In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells | Q45362666 | ||
| Optimal use of maraviroc in clinical practice | Q46266365 | ||
| CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice | Q47375281 | ||
| Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation. | Q47439250 | ||
| Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitors | Q47754842 | ||
| Premature age-related comorbidities among HIV-infected persons compared with the general population. | Q51000618 | ||
| Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study. | Q51299240 | ||
| Chronic renal failure among HIV-1-infected patients. | Q51914547 | ||
| Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. | Q54057499 | ||
| Immune surveillance in multiple sclerosis patients treated with natalizumab. | Q54606407 | ||
| 2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis | Q56985984 | ||
| Class of Antiretroviral Drugs and the Risk of Myocardial Infarction | Q57181081 | ||
| Inflammation, Immune Activation, and CVD Risk in Individuals With HIV Infection | Q58375394 | ||
| Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients | Q61439957 | ||
| Cardiovascular manifestations of HIV infection | Q61703416 | ||
| Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy | Q73162446 | ||
| Dilated cardiomyopathy associated with simian AIDS in nonhuman primates | Q73358617 | ||
| Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice | Q74093550 | ||
| Quantification of histochemical staining by color deconvolution | Q74448733 | ||
| Phenotypic variation in myocardial macrophage populations suggests a role for macrophage activation in SIV-associated cardiac disease | Q80344800 | ||
| Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis | Q80382565 | ||
| Effects of HMG-CoA reductase inhibitor on experimental autoimmune myocarditis | Q83554225 | ||
| Natalizumab for moderate to severe Crohn's disease in clinical practice: the Mayo Clinic Rochester experience | Q83656106 | ||
| Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial | Q95823071 | ||
| P433 | issue | 7 | |
| P577 | publication date | 2015-07-16 | |
| P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
| P1476 | title | Anti-α4 Integrin Antibody Blocks Monocyte/Macrophage Traffic to the Heart and Decreases Cardiac Pathology in a SIV Infection Model of AIDS. | |
| P478 | volume | 4 |
| Q38628801 | An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge? |
| Q36962445 | Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway |
| Q92090980 | Coronary Microvascular Dysfunction in HIV: A Review |
| Q38988925 | Direct Targeting of Macrophages With Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology |
| Q57652376 | Effects of an ActRIIB.Fc Ligand Trap on Cardiac Function in Simian Immunodeficiency Virus-Infected Male Rhesus Macaques |
| Q92643237 | HIV infection and coronary heart disease: mechanisms and management |
| Q40131063 | HIV-Associated Cardiovascular Disease: Role of Connexin 43. |
| Q41933419 | Insights into the Impact of CD8+ Immune Modulation on Human Immunodeficiency Virus Evolutionary Dynamics in Distinct Anatomical Compartments by Using Simian Immunodeficiency Virus-Infected Macaque Models of AIDS Progression |
| Q38631821 | Integrins and integrin-related proteins in cardiac fibrosis |
| Q98158482 | Interactions of Monocytes, HIV, and ART Identified by an Innovative scRNAseq Pipeline: Pathways to Reservoirs and HIV-Associated Comorbidities |
| Q59359816 | Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection |
| Q33751356 | Macrophages and HIV-1: An Unhealthy Constellation |
| Q47141408 | Myeloid Cell Interaction with HIV: A Complex Relationship. |
| Q91811483 | The HIV Reservoir in Monocytes and Macrophages |
| Q37057132 | α4-Integrin Antibody Treatment Blocks Monocyte/Macrophage Traffic to, Vascular Cell Adhesion Molecule-1 Expression in, and Pathology of the Dorsal Root Ganglia in an SIV Macaque Model of HIV-Peripheral Neuropathy |
Search more.